Filing Details

Accession Number:
0001104659-22-122555
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-28 21:44:16
Reporting Period:
2022-11-28
Accepted Time:
2022-11-28 21:44:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Iovance Biotherapeutics Inc. IOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210317 A Merrill Mcpeak C/O Iovance Biotherapeutics, Inc.
825 Industrial Road, 4Th Floor
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-28 10,000 $6.18 228,633 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 60,150 Direct
Footnotes
  1. These shares are held by a family trust for which the reporting person is a trustee.